Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2008-04-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINTE-GENEVIEVE-DES-BOIS (91700), Essonne
PHARMACIE DU DONJON : revenue, balance sheet and financial ratios
PHARMACIE DU DONJON is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINTE-GENEVIEVE-DES-BOIS (91700),
this company of category PME
shows in 2022 a revenue of 3.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU DONJON (SIREN 503284259)
Indicator
2024
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
N/C
3 629 609 €
2 929 635 €
2 941 747 €
2 951 753 €
2 820 979 €
2 714 192 €
Net income
63 436 €
156 346 €
184 322 €
67 517 €
48 513 €
511 459 €
119 519 €
157 104 €
EBITDA
N/C
N/C
415 730 €
96 609 €
63 891 €
142 049 €
178 773 €
151 031 €
Net margin
N/C
N/C
5.1%
2.3%
1.6%
17.3%
4.2%
5.8%
Revenue and income statement
In 2024, PHARMACIE DU DONJON generates positive net income of 63 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 157 k€ -> 63 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
63 436 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 281%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
280.653%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
22.957%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Debt ratio
35.79
32.312
19.633
17.372
14.631
302.8
272.877
280.653
Financial autonomy
68.091
69.623
77.069
78.398
80.259
20.998
23.43
22.957
Repayment capacity
6.444
7.483
7.616
10.379
7.129
10.752
None
None
Cash flow / Revenue
6.189%
4.739%
3.199%
2.109%
2.649%
6.562%
None%
None%
Sector positioning
Debt ratio
280.652024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DU DONJON (280.65) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
22.96%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE DU DONJON (23.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
10.75 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DU DONJON (10.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.926
Liquidity indicators evolution PHARMACIE DU DONJON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Liquidity ratio
115.876
124.453
585.304
571.855
570.172
179.719
183.921
164.926
Interest coverage
18.04
12.323
12.606
26.314
15.581
24.724
None
None
Sector positioning
Liquidity ratio
164.932024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of PHARMACIE DU DONJON (164.93) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
24.72x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE DU DONJON (24.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU DONJON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
2024
Operating WCR
260 101 €
325 428 €
2 063 157 €
2 055 399 €
2 004 749 €
355 411 €
0 €
0 €
Inventory turnover (days)
38
34
32
33
33
31
0
0
Customer payment term (days)
6
5
8
8
3
4
0
0
Supplier payment term (days)
45
43
46
47
46
60
0
0
Positioning of PHARMACIE DU DONJON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU DONJON is estimated at
885 613 €
(range 616 727€ - 1 324 928€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
616k€885k€1324k€
885 613 €Range: 616 727€ - 1 324 928€
NAF 5 année 2024
Valuation method used
Net Income Multiple
63 436 €
×
14.0x
=885 613 €
Range: 616 727€ - 1 324 928€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU DONJON with other companies in the same sector:
Frequently asked questions about PHARMACIE DU DONJON
What is the revenue of PHARMACIE DU DONJON ?
The revenue of PHARMACIE DU DONJON in 2022 is 3.6 M€.
Is PHARMACIE DU DONJON profitable?
Yes, PHARMACIE DU DONJON generated a net profit of 63 k€ in 2024.
Where is the headquarters of PHARMACIE DU DONJON ?
The headquarters of PHARMACIE DU DONJON is located in SAINTE-GENEVIEVE-DES-BOIS (91700), in the department Essonne.
Where to find the tax return of PHARMACIE DU DONJON ?
The tax return of PHARMACIE DU DONJON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU DONJON operate?
PHARMACIE DU DONJON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart